Date: 2024/11/03 - 00:50
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive function by reducing inflammation.
Recent research zooms in on the brain's own 'waste-disposal' system, with the aim of uncovering potential strategies to protect brain health and prevent cognitive decline.
A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do not carrry the genetic mutation that predisposes them to dementia.
A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect the heart. However, certain doses and delivery systems can lead to side effects affecting the gut.
A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a second phase that aggressively damages the brain.
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows.
Two blood tests currently in development have shown 'very high accuracy' in detecting tell-tale signs of Alzheimer's disease, according to the developers.
Date: 2024/10/19 - 19:40
NIH-funded study supports no change to surgical technique for trichiasis management.
Date: 2024/10/19 - 01:25
NIH takes very seriously allegations of research misconduct.